Shanghai Qingsong Pharmaceutical Co., Ltd

Business Type:Manufacturer

Main Products:Entecavir API and Intermediates,Dabigatran Etexilate Mesylate API/Intermediates ,Imidapril Hydrochloride Intermediates,Metixene Hydrochloride,Decitabine Intermediates,4-[4-Fluorobenzoyl]butyric acid,4-{[(4-Fluoropheny)imino]methyl}phenol,N-Boc-Cis-4-Fluoro-L-Proline,N-Boc-Cis-4-Fluoro-D-Proline,(S/R)-111-Trifluoroisopropylamine Hcl

Country/Region:China

Year Established:2005

Ddu Verified

HOT Rank

8/10
Company Information

Shanghai Qingsong Pharmaceutical Co., Ltd is a subsidiary of Yabao Pharmaceutical Group, is an emerging pharmaceutical company devoted its research &production in the areas of APIs and Pharmaceutical Intermediates, and achieved GMP(2010)/ISO9001/ISO14001/OHSAS18001:2007 certification.

R&D center covers an area of 3000 square meters with a more than 40 members team of highly qualified and experienced chemists. 70% of our R&D team members have received master of science degree and higher. The lab is well equipped with modern analytical instrument to satisfy our R&D needs.

The factory is located in Shanghai Fengxian Chemical Industrial Zone covering an area of more than 30000 square meters. It consists of a solid dosage pharmaceutical plant, multipurpose synthetic plant and API plant. Operating as per GMP system, and passed many multinational pharmaceutical companies QA & HSE audits.


We mainly provide following services to customers:

  • CMO for APIs & Intermediates

  • FTE chemical development services

  • Lincense in/out for products of mutual intersts

  • JV partnership for new product & technology

Email to this supplier
To

Send

Inquiry Cart(0)